Literature DB >> 18931007

Cranial autonomic symptoms in migraine: characteristics and comparison with cluster headache.

T-H Lai1, J-L Fuh, S-J Wang.   

Abstract

BACKGROUND: Cranial autonomic symptoms (CAS) are distinguishing features of trigeminal autonomic cephalalgias, of which cluster headache (CH) is the most common, but they can occur in patients with migraine. For migraine with strictly unilateral headache, the presence of CAS might cause diagnostic confusion with CH. Characteristics of CAS in migraine and comparisons with those in CH have rarely been reported.
METHODS: This study prospectively recruited consecutive patients with migraine and CH treated at a headache clinic. Six CAS items were surveyed, including: conjunctival injection, lacrimation, nasal congestion, rhinorrhoea, eyelid oedema and forehead/facial sweating. The CAS characteristics recorded included: laterality, intensity, time sequence and consistency with headache attacks.
RESULTS: A total of 786 migraine patients (625 women/161 men, mean age 40 (13) years) and 98 CH patients (11 women/87 men, mean age 36 (11) years) were recruited. The prevalence of > or =1 CAS in migraine patients was 56% and did not differ among migraine subtypes. Except for forehead/facial sweating, the features of the other CAS differed between patients with migraine and CH: CAS in migraine tended to be bilateral (OR 5.8-23.8 among different CAS), be unrestricted to the headache sides (OR 5.0-20.4), appear with mild to moderate intensity (OR 1.7-7.7) and be inconsistent with headache attacks (OR 2.8-6.7).
CONCLUSIONS: CAS were present in half of our migraine patients and the clinical features may help differentiate migraine from CH.

Entities:  

Mesh:

Year:  2008        PMID: 18931007     DOI: 10.1136/jnnp.2008.157743

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  40 in total

1.  A case of strictly unilateral migraine without aura transformed in an episodic hemicrania continua.

Authors:  Rossana Terlizzi; Sabina Cevoli; Marianna Nicodemo; Giulia Pierangeli; Daniela Grimaldi; Pietro Cortelli
Journal:  Neurol Sci       Date:  2010-10-06       Impact factor: 3.307

Review 2.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

Review 3.  Update on animal models of migraine.

Authors:  Marcela Romero-Reyes; Simon Akerman
Journal:  Curr Pain Headache Rep       Date:  2014-11

Review 4.  Primary headache disorders and neuro-ophthalmologic manifestations.

Authors:  Daniel P Schwartz; Matthew S Robbins
Journal:  Eye Brain       Date:  2012-09-13

Review 5.  Red Ear Syndrome.

Authors:  V Raieli; A Compagno; M D'Amelio
Journal:  Curr Pain Headache Rep       Date:  2016-03

6.  Neural mechanism for hypothalamic-mediated autonomic responses to light during migraine.

Authors:  Rodrigo Noseda; Alice J Lee; Rony-Reuven Nir; Carolyn A Bernstein; Vanessa M Kainz; Suzanne M Bertisch; Catherine Buettner; David Borsook; Rami Burstein
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-26       Impact factor: 11.205

7.  Cluster headache and oxygen: is it possible to predict which patients will be relieved? A prospective cross-sectional correlation study.

Authors:  D Y P Haane; L M E de Ceuster; R P J Geerlings; T H T Dirkx; P J Koehler
Journal:  J Neurol       Date:  2013-07-14       Impact factor: 4.849

8.  Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas.

Authors:  L Becerra; J Bishop; G Barmettler; Y Xie; E Navratilova; F Porreca; D Borsook
Journal:  J Neurophysiol       Date:  2015-10-21       Impact factor: 2.714

Review 9.  Neuropeptides as a Marker for Chronic Headache.

Authors:  Nuria Riesco; Eva Cernuda-Morollón; Julio Pascual
Journal:  Curr Pain Headache Rep       Date:  2017-04

10.  Cranial autonomic symptoms in pediatric migraine are the rule, not the exception.

Authors:  Amy A Gelfand; Amanda C Reider; Peter J Goadsby
Journal:  Neurology       Date:  2013-06-28       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.